Contracts › 75A50325F80036
75A50325F80036: Procurent of Xofluza (Baloxavir Marboxil) 40MG and 80MG Tablets
Awarded to Genentech Usa, Inc by Office of Assistant Secretary for Preparedness and Response.
$37.5Mobligated
$75.0Mpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50325F80036 |
|---|---|
| Vehicle | 36F79723D0219 |
| Awardee | Genentech Usa, Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | ASPR/ORM-SNS |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | CA |
| Offers received | 1 |
| Period of performance | 26 September 2025 to 29 September 2027 |
| Potential end | 29 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record